SwePub
Sök i LIBRIS databas

  Utökad sökning

WFRF:(Fall Katja)
 

Sökning: WFRF:(Fall Katja) > (2010-2014) > Genetic Variation A...

LIBRIS Formathandbok  (Information om MARC21)
FältnamnIndikatorerMetadata
00005487naa a2200517 4500
001oai:DiVA.org:oru-35809
003SwePub
008140730s2014 | |||||||||||000 ||eng|
0247 a https://urn.kb.se/resolve?urn=urn:nbn:se:oru:diva-358092 URI
0247 a https://doi.org/10.1002/pros.228202 DOI
040 a (SwePub)oru
041 a engb eng
042 9 SwePub
072 7a ref2 swepub-contenttype
072 7a art2 swepub-publicationtype
1001 a Markt, Sarah C.u Sch Publ Hlth, Dept Epidemiol, Harvard Univ, Boston, USA4 aut
2451 0a Genetic Variation Across C-Reactive Protein and Risk of Prostate Cancer
264 c 2014-05-20
264 1b Wiley-Blackwell,c 2014
338 a print2 rdacarrier
500 a Funding Agencies:Prostate Cancer FoundationNational Cancer Institute CA42182  CA34944  CA40360  CA141298  CA097193National Heart, Lung, and Blood Institute (Bethesda, MD) HL26490  HL34595
520 a BACKGROUND. Inflammation has been hypothesized to play an important etiological role in the initiation or progression of prostate cancer. Circulating levels of the systemic inflammation marker C-reactive protein (CRP) have been associated with increased risk of prostate cancer. We investigated the role of genetic variation in CRP and prostate cancer, under the hypothesis that variants may alter risk of disease.METHODS. We undertook a case-control study nested within the prospective Physicians' Health Study among 1,286 men with incident prostate cancer and 1,264 controls. Four single-nucleotide polymorphisms (SNPs) were selected to capture the common genetic variation across CRP (r(2) > 0.8). We used unconditional logistic regression to assess the association between each SNP and risk of prostate cancer. Linear regression models explored associations between each genotype and plasma CRP levels.RESULTS. None of the CRP SNPs were associated with prostate cancer overall. Individuals with one copy of the minor allele (C) in rs1800947 had an increased risk of high-grade prostate cancer (OR: 1.7; 95% CI: 1.1-2.8), and significantly lower mean CRP levels (P-value < 0.001), however, we found no significant association with lethal disease. Mean CRP levels were significantly elevated in men with one or two copies of the minor allele in rs3093075 and rs1417939, but these were unrelated to prostate cancer risk.CONCLUSION. Our findings suggest that SNPs in the CRP gene are not associated with risk of overall or lethal prostate cancer. Polymorphisms in CRP rs1800947 may be associated with higher grade disease, but our results require replication in other cohorts.
650 7a MEDICIN OCH HÄLSOVETENSKAPx Klinisk medicinx Cancer och onkologi0 (SwePub)302032 hsv//swe
650 7a MEDICAL AND HEALTH SCIENCESx Clinical Medicinex Cancer and Oncology0 (SwePub)302032 hsv//eng
650 7a MEDICIN OCH HÄLSOVETENSKAPx Klinisk medicinx Endokrinologi och diabetes0 (SwePub)302052 hsv//swe
650 7a MEDICAL AND HEALTH SCIENCESx Clinical Medicinex Endocrinology and Diabetes0 (SwePub)302052 hsv//eng
650 7a MEDICIN OCH HÄLSOVETENSKAPx Klinisk medicinx Urologi och njurmedicin0 (SwePub)302142 hsv//swe
650 7a MEDICAL AND HEALTH SCIENCESx Clinical Medicinex Urology and Nephrology0 (SwePub)302142 hsv//eng
653 a CRP SNPs
653 a prostate cancer
653 a inflammation
653 a Onkologi
653 a Oncology
7001 a Rider, Jennifer R.u Sch Publ Hlth, Dept Epidemiol, Harvard Univ, Boston, USA; Dept Med, Channing Div Network Med, Brigham & Womens Hosp, Boston, USA; Sch Med, Harvard Univ, Boston, USA4 aut
7001 a Penney, Kathryn L.u Sch Publ Hlth, Dept Epidemiol, Harvard Univ, Boston, USA; Dept Med, Channing Div Network Med, Brigham & Womens Hosp, Boston, USA; Sch Med, Harvard Univ, Boston, USA4 aut
7001 a Schumacher, Fredrick R.u Keck Sch Med, Dept Prevent Med, Univ So Calif, Los Angeles, USA4 aut
7001 a Epstein, Mara M.u Sch Publ Hlth, Dept Epidemiol, Harvard Univ, Boston, USA; Dept Med, Channing Div Network Med, Brigham & Womens Hosp, Boston, USA; Sch Med, Harvard Univ, Boston, USA4 aut
7001 a Fall, Katja,d 1971-u Örebro universitet,Institutionen för hälsovetenskap och medicin,Department of Epidemiology, Harvard School of Public Health, Boston MA, United States,Clinical Epidemiology and Biostatistics4 aut0 (Swepub:oru)kafl
7001 a Sesso, Howard D.u Dept Med, Div Prevent Med, Brigham & Womens Hosp, Boston, USA; Sch Med, Harvard Univ, Boston, USA4 aut
7001 a Stampfer, Meir J.u Sch Publ Hlth, Dept Epidemiol, Harvard Univ, Boston, USA; Dept Med, Channing Div Network Med, Brigham & Womens Hosp, Boston, USA; Sch Med, Harvard Univ, Boston, USA4 aut
7001 a Mucci, Lorelei A.u Sch Publ Hlth, Dept Epidemiol, Harvard Univ, Boston, USA; Dept Med, Channing Div Network Med, Brigham & Womens Hosp, Boston, USA; Sch Med, Harvard Univ, Boston, USA4 aut
7102 a Sch Publ Hlth, Dept Epidemiol, Harvard Univ, Boston, USAb Sch Publ Hlth, Dept Epidemiol, Harvard Univ, Boston, USA; Dept Med, Channing Div Network Med, Brigham & Womens Hosp, Boston, USA; Sch Med, Harvard Univ, Boston, USA4 org
7730 t The Prostated : Wiley-Blackwellg 74:10, s. 1034-1042q 74:10<1034-1042x 0270-4137x 1097-0045
8564 u https://europepmc.org/articles/pmc4063346?pdf=render
8564 8u https://urn.kb.se/resolve?urn=urn:nbn:se:oru:diva-35809
8564 8u https://doi.org/10.1002/pros.22820

Hitta via bibliotek

Till lärosätets databas

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy